Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA-Reference-Cited by-全球学者库

Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA

Published:2021-12-30 Issue:27 Volume:385 Page:2520-2530
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Wang Yongjun¹^ORCID,Meng Xia¹,Wang Anxin¹,Xie Xuewei¹,Pan Yuesong¹,Johnston S. Claiborne¹,Li Hao¹,Bath Philip M.¹^ORCID,Dong Qiang¹,Xu Anding¹^ORCID,Jing Jing¹^ORCID,Lin Jinxi¹,Niu Siying¹,Wang Yilong¹,Zhao Xingquan¹,Li Zixiao¹,Jiang Yong¹^ORCID,Li Wei¹,Liu Liping¹,Xu Jie¹,Chang Liguo¹,Wang Lihua¹,Zhuang Xianbo¹,Zhao Jinguo¹,Feng Yefang¹,Man Honghao¹,Li Guozhong¹,Wang Baojun¹

Affiliation:

1. From the China National Clinical Research Center for Neurological Diseases (Yongjun Wang, X.M., A.W., X.X., Y.P., H.L., J.J., J.L., S.N., Yilong Wang, X. Zhao, Z.L., Y.J., W.L., L.L., J.X.), the Department of Neurology (Yongjun Wang, X.M., A.W., X.X., Y.P., H.L., J.J., J.L., S.N., Yilong Wang, X. Zhao, Z.L., Y.J., W.L., L.L., J.X.), and the Advanced Innovation Center for Human Brain Protection (Yongjun Wang), Beijing Tiantan Hospital, Capital Medical University, and the Research Unit of Artificial...

Funder

Ministry of Science and Technology of the People’s Republic of China

Chinese Stroke Association

Beijing Municipal Science & Technology Commission

National Science and Technology Major Project

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2111749

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial;Neurology;2024-02-13

2. Optimal Medical Management of Atherosclerotic Intracranial Stenosis;Stroke;2024-02

3. Randomized Secondary Prevention Trials in Participants With Symptomatic Intracranial Atherosclerotic Stenosis;Stroke;2024-02

4. Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, An Updated Review;Journal of Cardiovascular Development and Disease;2024-01-31

5. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial;Stroke and Vascular Neurology;2024-01-29